Clinical trial
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent…
NCT00461786 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00461786 |
|---|---|
| Title | A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer |
| Official title | A Phase II Evaluation of Pemetrexed (Alimta, LY231514l, IND # 40061) in the Treatment of Recurrent or Persistent Platinum Resistant Ovarian or Primary Peritoneal Carcinoma |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Gynecologic Oncology Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Peritoneal Cancer |
| Intervention type | Drug |
| Interventions | pemetrexed |
| Enrollment | 51 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Dec 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: